The APOE4 allele is associated with a decreased risk of retinopathy in type 2 diabetics

Zheng Y, Ley SH, Hu FB (2018) Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 14:88–98. https://doi.org/10.1038/nrendo.2017.151 Tao Z, Shi A, Zhao J (2015) Epidemiological perspectives of diabetes. Cell Biochem Biophys 73:181–185. https://doi.org/10.1007/s12013-015-0598-4 Balakumar P, Maung-U K, Jagadeesh G (2016) Prevalence and prevention of cardiovascular disease and diabetes mellitus. Pharmacol Res 113:600–609. https://doi.org/10.1016/j.phrs.2016.09.040 Fletcher B, Gulanick M, Lamendola C (2002) Risk factors for type 2 diabetes mellitus. J Cardiovasc Nurs 16:17–23. https://doi.org/10.1097/00005082-200201000-00003 Stephenson EJ, Smiles W, Hawley JA (2014) The relationship between exercise, nutrition and type 2 diabetes. Med Sport Sci 60:1–10. https://doi.org/10.1159/000357331 Hubácek JA (2009) Eat less and exercise more - is it really enough to knock down the obesity pandemia? Physiol Res 58(Suppl 1):S1–S6 Romieu I, Dossus L, Barquera S, Blottière HM, Franks PW, Gunter M et al (2017) Energy balance and obesity: what are the main drivers? Cancer Causes Control 28:247–258. https://doi.org/10.1007/s10552-017-0869-z Cole JB, Florez JC (2020) Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol 16:377–390. https://doi.org/10.1038/s41581-020-0278-5 Dlouhá D, Hubáček JA (2012) FTO gene and his role in genetic determination of obesity. Article in Czech Vnitr Lek 58:208–215 Stančáková A, Laakso M (2016) Genetics of type 2 diabetes. Endocr Dev 31:203–220. https://doi.org/10.1159/000439418 Climent E, Pérez-Calahorra S, Marco-Benedí V, Plana N, Sánchez R, Ros E et al (2017) Effect of LDL cholesterol, statins and presence of mutations on the prevalence of type 2 diabetes in heterozygous familial hypercholesterolemia. Sci Rep 7:5596. https://doi.org/10.1038/s41598-017-06101-6 Besseling J, Kastelein JJ, Defesche JC, Hutten BA, Hovingh GK (2015) Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus. JAMA 313:1029–1036. https://doi.org/10.1001/jama.2015.1206 Maki KC, Diwadkar-Navsariwala V, Kramer MW (2018) Statin use and risk for type 2 diabetes: what clinicians should know. Postgrad Med 130:166–172. https://doi.org/10.1080/00325481.2018.1402658 Lotta LA, Sharp SJ, Burgess S, Perry JRB, Stewart ID, Willems SM et al (2016) Association between low-density lipoprotein cholesterol-lowering genetic variants and risk of type 2 diabetes: a meta-analysis. JAMA 316:1383–1391. https://doi.org/10.1001/jama.2016.14568 Swerdlow DI, Preiss D, Kuchenbaecker KB, Holmes MV, Engmann JE, Shah T et al (2015) HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials. Lancet 385:351–361. https://doi.org/10.1016/S0140-6736(14)61183-1 Davignon J, Gregg RE, Sing CF (1988) Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8:1–21. https://doi.org/10.1161/01.atv.8.1.1 Hubacek JA, Vrablik M (2011) Effect of apolipoprotein E polymorphism on statin-induced decreases in plasma lipids and cardiovascular events. Drug Metabol Drug Interact 26:13–20. https://doi.org/10.1515/DMDI.2011.107 Hubácek JA, Pitha J, Adámková V, Skodová Z, Lánská V, Poledne R (2003) Apolipoprotein E and apolipoprotein CI polymorphisms in the Czech population: almost complete linkage disequilibrium of the less frequent alleles of both polymorphisms. Physiol Res 52:195–200 Anthopoulos PG, Hamodrakas SJ, Bagos PG (2010) Apolipoprotein E polymorphisms and type 2 diabetes: a meta-analysis of 30 studies including 5423 cases and 8197 controls. Mol Genet Metab 100:283–291. https://doi.org/10.1016/j.ymgme.2010.03.008 Yin YW, Qiao L, Sun QQ, Hu AM, Liu HL, Wang Q et al (2014) Influence of apolipoprotein E gene polymorphism on development of type 2 diabetes mellitus in Chinese Han population: a meta-analysis of 29 studies. Metabolism 63:532–541. https://doi.org/10.1016/j.metabol.2013.12.008 Xiying M, Wenbo W, Wangyi F, Qinghuai L (2017) Association of apolipoprotein E polymorphisms with age-related macular degeneration subtypes: an updated systematic review and meta-analysis. Arch Med Res 48:370–377. https://doi.org/10.1016/j.arcmed.2017.08.002 Toops KA, Tan LX, Lakkaraju A (2016) Apolipoprotein E isoforms and AMD. Adv Exp Med Biol 854:3–9. https://doi.org/10.1007/978-3-319-17121-0_1 Mahley RW (2016) Central nervous system lipoproteins: ApoE and regulation of cholesterol metabolism. Arterioscler Thromb Vasc Biol 36:1305–1315. https://doi.org/10.1161/ATVBAHA.116.307023 Hubacek JA, Bloudickova S, Kubinova R, Pikhart H, Viklicky O, Bobak M (2009) Apolipoprotein E polymorphism in hemodialyzed patients and healthy controls. Biochem Genet 47:688–693. https://doi.org/10.1007/s10528-009-9266-y Xue C, Nie W, Tang D, Yi L, Mei C (2013) Apolipoprotein E gene variants on the risk of end stage renal disease. PLoS ONE 8:e83367. https://doi.org/10.1371/journal.pone.0083367 Hubáček JA, Neškudla T, Klementová M, Adámková V, Pelikánová T (2013) Tagging rs10811661 variant at CDKN2A/2B locus is not associated with type 2 diabetes mellitus in Czech population. Folia Biol (Praha) 59:168–171 Hubacek JA, Dlouha D, Klementova M, Lanska V, Neskudla T, Pelikanova T (2018) The FTO variant is associated with chronic complications of diabetes mellitus in Czech population. Gene 642:220–224. https://doi.org/10.1016/j.gene.2017.11.040 Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS et al (2011) Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabet Care 34:e61–e69. https://doi.org/10.2337/dc11-9998 Jones AG, Hattersley AT (2013) The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabet Med 30:803–817. https://doi.org/10.1111/dme.12159 Cífková R, Bruthans J, Wohlfahrt P, Krajčoviechová A, Šulc P, Jozífová M et al (2020) 30-year trends in major cardiovascular risk factors in the Czech population, Czech MONICA and Czech post-MONICA, 1985–2016/17. PLoS ONE 15:e0232845. https://doi.org/10.1371/journal.pone.0232845 Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215. https://doi.org/10.1093/nar/16.3.1215 Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31:545–548 Hubacek JA, Pitha J, Skodová Z, Adámková V, Lánská V, Poledne R (2001) A possible role of apolipoprotein E polymorphism in predisposition to higher education. Neuropsychobiology 43:200–203. https://doi.org/10.1159/000054890 Hubáček JA, Pikhart H, Peasey A, Kubínová R, Bobák M (2015) Nobody is perfect: comparison of the accuracy of PCR-RFLP and KASP™ method for genotyping. ADH1B and FTO polymorphisms as examples. Folia Biol (Praha) 61:156–160 Tao QQ, Chen Y, Liu ZJ, Sun YM, Yang P, Lu SJ et al (2014) Associations between apolipoprotein E genotypes and serum levels of glucose, cholesterol, and triglycerides in a cognitively normal aging Han Chinese population. Clin Interv Aging 9:1063–1067. https://doi.org/10.2147/CIA.S62554 Fuentes F, Alcala-Diaz JF, Watts GF, Alonso R, Muñiz O, Díaz-Díaz JL et al (2015) Statins do not increase the risk of developing type 2 diabetes in familial hypercholesterolemia: the SAFEHEART study. Int J Cardiol 201:79–84. https://doi.org/10.1016/j.ijcard.2015.07.107 Vrablik M, Tichy L, Freiberger T, Blaha V, Satny M, Hubacek JA (2020) Genetics of familial hypercholesterolemia: new insights. Front Genet 11:574474. https://doi.org/10.3389/fgene.2020.574474 Joyce NR, Zachariah JP, Eaton CB, Trivedi AN, Wellenius GA (2017) Statin use and the risk of type 2 diabetes mellitus in children and adolescents. Acad Pediatr 17:515–522. https://doi.org/10.1016/j.acap.2017.02.006 Talmud PJ, Cooper JA, Morris RW, Dudbridge F, Shah T, Engmann J et al (2015) Sixty-five common genetic variants and prediction of type 2 diabetes. Diabetes 64:1830–1840. https://doi.org/10.2337/db14-1504 Grarup N, Sandholt CH, Hansen T, Pedersen O (2014) Genetic susceptibility to type 2 diabetes and obesity: from genome-wide association studies to rare variants and beyond. Diabetologia 57:1528–1541. https://doi.org/10.1007/s00125-014-3270-4 Nurieva O, Hubacek JA, Urban P, Hlusicka J, Diblik P, Kuthan P et al (2019) Clinical and genetic determinants of chronic visual pathway changes after methanol - induced optic neuropathy: four-year follow-up study. Clin Toxicol (Phila) 57:387–397. https://doi.org/10.1080/15563650.2018.1532083 Zhang P, Gao J, Pu C, Zhang Y (2017) Apolipoprotein status in type 2 diabetes mellitus and its complications (Review). Mol Med Rep 16:9279–9286. https://doi.org/10.3892/mmr.2017.7831 Moreno JA, Pérez-Jiménez F, Moreno-Luna R, Pérez-Martínez P, Fuentes-Jiménez F, Marín C et al (2009) The effect of apoE genotype and sex on ApoE plasma concentration is determined by dietary fat in healthy subjects. Br J Nutr 101:1745–1752. https://doi.org/10.1017/S0007114508111515 Zhou Z, Hoke A, Cornblath DR, Griffin JW, Polydefkis M (2005) APOE epsilon4 is not a susceptibility gene in idiopathic or diabetic sensory neuropathy. Neurology 64:139–141. https://doi.org/10.1212/01.WNL.0000148587.97690.4E Monastiriotis C, Papanas N, Trypsianis G, Karanikola K, Veletza S, Maltezos E (2013) The ε4 allele of the APOE gene is associated with more severe peripheral neuropathy in type 2 diabetic patients. Angiology 64:451–455. https://doi.org/10.1177/0003319712453645 Forero DA, López-León S, González-Giraldo Y, Dries DR, Pereira-Morales AJ, Jiménez KM et al (2018) APOE gene and neuropsychiatric disorders and endophenotypes: a comprehensive review. Am J Med Genet B Neuropsychiatr Genet 177:126–142. https://doi.org/10.1002/ajmg.b.32516